相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
Rika Jimbo et al.
KIDNEY INTERNATIONAL (2014)
Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
Yifu Fang et al.
KIDNEY INTERNATIONAL (2014)
Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
Tamara Isakova et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The effect of phosphate binders, calcium and lanthanum carbonate on FGF23 levels in chronic kidney disease patients
Sagrario Soriano et al.
CLINICAL NEPHROLOGY (2013)
Expression of FGF23/KLOTHO system in human vascular tissue
Javier Donate-Correa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Cardiovascular Effects of Sevelamer in Stage 3 CKD
Colin D. Chue et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
Julia J. Scialla et al.
KIDNEY INTERNATIONAL (2013)
Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
Karolina Lindberg et al.
PLOS ONE (2013)
Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional study
Masaru Nakayama et al.
BMC NEPHROLOGY (2013)
Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study
Hyo Jin Kim et al.
BMC NEPHROLOGY (2013)
Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis
Chikako Nakano et al.
BONE (2012)
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
Kenneth Lim et al.
CIRCULATION (2012)
(1-34) Parathyroid Hormone Infusion Acutely Lowers Fibroblast Growth Factor 23 Concentrations in Adult Volunteers
Orlando M. Gutierrez et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease The PRIMO Randomized Controlled Trial
Ravi Thadhani et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol
Ditte Hansen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
Masahiro Koizumi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α
Yumie Aoshima et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Role of vitamin D in vascular calcification: bad guy or good guy?
Tilman B. Drueeke et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype
Hua Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo
Yumie Rhee et al.
BONE (2011)
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Catherine M. Shanahan et al.
CIRCULATION RESEARCH (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Oxidized Low-Density Lipoprotein Promotes Osteoblast Differentiation in Primary Cultures of Vascular Smooth Muscle Cells by Up-regulating Osterix Expression in an Msx2-Dependent Manner
Jesse Taylor et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix
Hong Zebger-Gong et al.
JOURNAL OF HYPERTENSION (2011)
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Jessica Kendrick et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
Keith Hruska et al.
KIDNEY INTERNATIONAL (2011)
Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in vivo
Ignacio Lopez et al.
KIDNEY INTERNATIONAL (2011)
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism
Katherine Wesseling-Perry et al.
KIDNEY INTERNATIONAL (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
Alper Kirkpantur et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
Tamara Isakova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients
Emilio Gonzalez-Parra et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate
Ana L. E. Cancela et al.
NEPHRON CLINICAL PRACTICE (2011)
Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
James B. Wetmore et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Rodrigo B. Oliveira et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Fibroblast Growth Factor-23 in Early Chronic Kidney Disease: Additional Support in Favor of a Phosphate-Centric Paradigm for the Pathogenesis of Secondary Hyperparathyroidism
Pieter Evenepoel et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Ming Chang Hu et al.
FASEB JOURNAL (2010)
Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients
Mustafa Balci et al.
HEMODIALYSIS INTERNATIONAL (2010)
Both FGF23 and Extracellular Phosphate Activate Raf/MEK/ERK Pathway via FGF Receptors in HEK293 Cells
Miwa Yamazaki et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
The Calcemic Response to Continuous Parathyroid Hormone (PTH)(1-34) Infusion in End-Stage Kidney Disease Varies According to Bone Turnover: A Potential Role for PTH(7-84)
Katherine Wesseling-Perry et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
FGF23 Fails to Inhibit Uremic Parathyroid Glands
Rocio Canalejo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Increased parathyroid expression of klotho in uremic rats
Jacob Hofman-Bang et al.
KIDNEY INTERNATIONAL (2010)
FGF23-parathyroid interaction: implications in chronic kidney disease
Hirotaka Komaba et al.
KIDNEY INTERNATIONAL (2010)
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
Hisashi Hasegawa et al.
KIDNEY INTERNATIONAL (2010)
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
Mohamed M. Nasrallah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Sarah Seiler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Hannes Olauson et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Fibroblast growth factor 23 production in bone is directly regulated by 1α,25-dihydroxyvitamin D, but not PTH
Fumie Saji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease
Jane L. Finch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)
Rohit Bhuriya et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition
Ritsuko Nakano-Kurimoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
Heng Jung Hsu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Orlando M. Gutierrez et al.
CIRCULATION (2009)
Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries
Mei Y. Speer et al.
CIRCULATION RESEARCH (2009)
Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA
Joachim H. Ix et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Effects of hPTH(1-34) Infusion on Circulating Serum Phosphate, 1,25-Dihydroxyvitamin D, and FGF23 Levels in Healthy Men
Sherri-Ann M. Burnett-Bowie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Association of Serum Phosphate with Vascular and Valvular Calcification in Moderate CKD
Kathryn L. Adeney et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1
Jyothsna Gattineni et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Oral active vitamin D is associated with improved survival in hemodialysis patients
Manuel Naves-Diaz et al.
KIDNEY INTERNATIONAL (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The parathyroid is a target organ for FGF23 in rats
Iddo Z. Ben-Dov et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals
Natalya Bodyak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells
Tijana Krajisnik et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Characterization of phosphate transport in rat vascular smooth muscle cells - Implications for vascular calcification
Ricardo Villa-Bellosta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward
Myles Wolf et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts
Ritsuko Masuyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women
Sherri-Ann M. Burnett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D
Shiguang Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification
XW Li et al.
CIRCULATION RESEARCH (2006)
Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO)
S. Moe et al.
KIDNEY INTERNATIONAL (2006)
Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23
XJ Yu et al.
ENDOCRINOLOGY (2005)
Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism
T Shimada et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Sevelamer hydrochloride and calcium bicarbonate reduce serum fibroblast growth factor 23 levels in dialysis patients
F Koiwa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study
T Ninomiya et al.
KIDNEY INTERNATIONAL (2005)
Fibroblast growth factor 23 reduces expression of type IIa Na+/Pi co-transporter by signaling through a receptor functionally distinct from the known FGFRs in opossum kidney cells
XM Yan et al.
GENES TO CELLS (2005)
Activated injectable vitamin D and hemodialysis survival:: A historical cohort study
M Teng et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cellular signaling by fibroblast growth factor receptors
VP Eswarakumar et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Mechanisms underlying differential responses to FGF signaling
L Dailey et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
SL Ferrari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism
H Nishi et al.
NEPHRON CLINICAL PRACTICE (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
T Shimada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage
H Mitani et al.
HYPERTENSION (2002)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Severely reduced production of Klotho in human chronic renal failure kidney
N Koh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
Phosphate regulation of vascular smooth muscle cell calcification
S Jono et al.
CIRCULATION RESEARCH (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
